跳至主要内容
临床试验/CTRI/2022/07/043815
CTRI/2022/07/043815已完成不适用

THE EFFECT OF BEHAVIOURAL MODIFICATION THERAPY ON TOBACCO CESSATION AMONG PATIENTS VISITING A DENTAL INSTITUTION IN BANGALORE – AN EXPERIMENTAL STUDY.

ARUMUGAM P M1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年7月15日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
reduction in the consumption a number of cigarettes smoked and smokeless tobacco

研究概览

简要总结

India occupies a very special place in the world’s tobacco map. As the second most populous country in the world, India’s share of the global burden of tobacco induced disease and death is substantial and as the second largest producer and consumer of tobacco in the world.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • •Participants who will give informed consent to participate in the study. • Patients aged between
  • 80yrs. •Patients using tobacco for more than 6 months. •A patient using tobacco for more than 3 times per day. •No subjects should have undergone any behavioural counselling in the four-week period prior to the baseline examination.

排除标准

  • •Participants who don’t give informed consent to participate in the study.
  • •Pregnant or lactating females.
  • •Patient undergoing nicotine replacement therapy.
  • •Those who are undergoing antibiotic or anti-inflammatory therapy or on medication for any underlying systemic disorders.

结局指标

主要结局

reduction in the consumption a number of cigarettes smoked and smokeless tobacco

时间窗: baseline, 10th day, 30th day, 3 months, 6 months.

次要结局

  • Assess the complete abstinence for any form of tobacco use for at least a month(after six months)

研究者

发起方
ARUMUGAM P M
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验